Copy number and SNP arrays in clinical diagnostics

Christian P. Schaaf, Joanna Wiszniewska, Arthur L. Beaudet

Research output: Contribution to journalArticle

103 Citations (Scopus)

Abstract

The ability of chromosome microarray analysis (CMA) to detect submicroscopic genetic abnormalities has revolutionized the clinical diagnostic approach to individuals with intellectual disability, neurobehavioral phenotypes, and congenital malformations. The recognition of the underlying copy number variant (CNV) in respective individuals may allow not only for better counseling and anticipatory guidance but also for more specific therapeutic interventions in some cases. The use of CMA technology in prenatal diagnosis is emerging and promises higher sensitivity for several highly penetrant, clinically severe microdeletion and microduplication syndromes. Genetic counseling complements the diagnostic testing with CMA, given the presence of CNVs of uncertain clinical significance, incomplete penetrance, and variable expressivity in some cases. While oligonucleotide arrays with high-density exonic coverage remain the gold standard for the detection of CNVs, single-nucleotide polymorphism (SNP) arrays allow for detection of consanguinity and most cases of uniparental disomy and provide a higher sensitivity to detect low-level mosaic aneuploidies.

Original languageEnglish (US)
Pages (from-to)25-51
Number of pages27
JournalAnnual Review of Genomics and Human Genetics
Volume12
DOIs
StatePublished - Jul 13 2011
Externally publishedYes

Fingerprint

Microarray Analysis
Single Nucleotide Polymorphism
Chromosomes
Uniparental Disomy
Consanguinity
Aptitude
Penetrance
Genetic Counseling
Aneuploidy
Oligonucleotide Array Sequence Analysis
Prenatal Diagnosis
Intellectual Disability
Counseling
Technology
Phenotype
Therapeutics

Keywords

  • Consanguinity
  • Intellectual disability
  • Microarray
  • Mosaicism
  • Neuropsychiatric disorders
  • Prenatal diagnosis

ASJC Scopus subject areas

  • Molecular Biology
  • Genetics
  • Genetics(clinical)

Cite this

Copy number and SNP arrays in clinical diagnostics. / Schaaf, Christian P.; Wiszniewska, Joanna; Beaudet, Arthur L.

In: Annual Review of Genomics and Human Genetics, Vol. 12, 13.07.2011, p. 25-51.

Research output: Contribution to journalArticle

Schaaf, Christian P. ; Wiszniewska, Joanna ; Beaudet, Arthur L. / Copy number and SNP arrays in clinical diagnostics. In: Annual Review of Genomics and Human Genetics. 2011 ; Vol. 12. pp. 25-51.
@article{478cff32821e464386defcbbd64baf05,
title = "Copy number and SNP arrays in clinical diagnostics",
abstract = "The ability of chromosome microarray analysis (CMA) to detect submicroscopic genetic abnormalities has revolutionized the clinical diagnostic approach to individuals with intellectual disability, neurobehavioral phenotypes, and congenital malformations. The recognition of the underlying copy number variant (CNV) in respective individuals may allow not only for better counseling and anticipatory guidance but also for more specific therapeutic interventions in some cases. The use of CMA technology in prenatal diagnosis is emerging and promises higher sensitivity for several highly penetrant, clinically severe microdeletion and microduplication syndromes. Genetic counseling complements the diagnostic testing with CMA, given the presence of CNVs of uncertain clinical significance, incomplete penetrance, and variable expressivity in some cases. While oligonucleotide arrays with high-density exonic coverage remain the gold standard for the detection of CNVs, single-nucleotide polymorphism (SNP) arrays allow for detection of consanguinity and most cases of uniparental disomy and provide a higher sensitivity to detect low-level mosaic aneuploidies.",
keywords = "Consanguinity, Intellectual disability, Microarray, Mosaicism, Neuropsychiatric disorders, Prenatal diagnosis",
author = "Schaaf, {Christian P.} and Joanna Wiszniewska and Beaudet, {Arthur L.}",
year = "2011",
month = "7",
day = "13",
doi = "10.1146/annurev-genom-092010-110715",
language = "English (US)",
volume = "12",
pages = "25--51",
journal = "Annual Review of Genomics and Human Genetics",
issn = "1527-8204",
publisher = "Annual Reviews Inc.",

}

TY - JOUR

T1 - Copy number and SNP arrays in clinical diagnostics

AU - Schaaf, Christian P.

AU - Wiszniewska, Joanna

AU - Beaudet, Arthur L.

PY - 2011/7/13

Y1 - 2011/7/13

N2 - The ability of chromosome microarray analysis (CMA) to detect submicroscopic genetic abnormalities has revolutionized the clinical diagnostic approach to individuals with intellectual disability, neurobehavioral phenotypes, and congenital malformations. The recognition of the underlying copy number variant (CNV) in respective individuals may allow not only for better counseling and anticipatory guidance but also for more specific therapeutic interventions in some cases. The use of CMA technology in prenatal diagnosis is emerging and promises higher sensitivity for several highly penetrant, clinically severe microdeletion and microduplication syndromes. Genetic counseling complements the diagnostic testing with CMA, given the presence of CNVs of uncertain clinical significance, incomplete penetrance, and variable expressivity in some cases. While oligonucleotide arrays with high-density exonic coverage remain the gold standard for the detection of CNVs, single-nucleotide polymorphism (SNP) arrays allow for detection of consanguinity and most cases of uniparental disomy and provide a higher sensitivity to detect low-level mosaic aneuploidies.

AB - The ability of chromosome microarray analysis (CMA) to detect submicroscopic genetic abnormalities has revolutionized the clinical diagnostic approach to individuals with intellectual disability, neurobehavioral phenotypes, and congenital malformations. The recognition of the underlying copy number variant (CNV) in respective individuals may allow not only for better counseling and anticipatory guidance but also for more specific therapeutic interventions in some cases. The use of CMA technology in prenatal diagnosis is emerging and promises higher sensitivity for several highly penetrant, clinically severe microdeletion and microduplication syndromes. Genetic counseling complements the diagnostic testing with CMA, given the presence of CNVs of uncertain clinical significance, incomplete penetrance, and variable expressivity in some cases. While oligonucleotide arrays with high-density exonic coverage remain the gold standard for the detection of CNVs, single-nucleotide polymorphism (SNP) arrays allow for detection of consanguinity and most cases of uniparental disomy and provide a higher sensitivity to detect low-level mosaic aneuploidies.

KW - Consanguinity

KW - Intellectual disability

KW - Microarray

KW - Mosaicism

KW - Neuropsychiatric disorders

KW - Prenatal diagnosis

UR - http://www.scopus.com/inward/record.url?scp=80052763003&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=80052763003&partnerID=8YFLogxK

U2 - 10.1146/annurev-genom-092010-110715

DO - 10.1146/annurev-genom-092010-110715

M3 - Article

C2 - 21801020

AN - SCOPUS:80052763003

VL - 12

SP - 25

EP - 51

JO - Annual Review of Genomics and Human Genetics

JF - Annual Review of Genomics and Human Genetics

SN - 1527-8204

ER -